Rize Oncology Inc. (CSE:RIZE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0600
-0.0600 (-50.00%)
Apr 1, 2025, 9:30 AM EST

Rize Oncology Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Market Capitalization
525---
Upgrade
Market Cap Growth
-66.05%-67.83%----
Upgrade
Enterprise Value
3-02---
Upgrade
Last Close Price
0.060.040.10---
Upgrade
PB Ratio
1.740.861.92---
Upgrade
P/TBV Ratio
0.440.861.92---
Upgrade
Debt / Equity Ratio
-----1.57-2.45
Upgrade
Quick Ratio
32.8335.3320.540.840.370.47
Upgrade
Current Ratio
34.5236.5622.241.740.370.61
Upgrade
Return on Equity (ROE)
-57.85%-42.64%-170.34%-4122.37%--1700.47%
Upgrade
Return on Assets (ROA)
-37.98%-27.84%-92.74%-492.06%-153.75%-258.60%
Upgrade
Return on Capital (ROIC)
-38.92%-28.93%-106.58%-1015.04%-159.59%-353.64%
Upgrade
Earnings Yield
-20.72%-58.66%-48.18%---
Upgrade
Buyback Yield / Dilution
10.68%-7.75%-20.45%-32.93%-3729.11%-43.40%
Upgrade
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.